WEBINAR: CDIAC Transition to CADTH
Автор: Canadian Cancer Survivor Network
Загружено: 2019-03-15
Просмотров: 149
Don’t miss our upcoming webinars: Subscribe today!
This webinar was hosted by Gerry Jeffcott from 3Sixty Public Affairs. He summarized some important changes that the Canadian Agency for Drugs and Technologies in Health (CADTH) has proposed to the way pCODR reviews new cancer medications and outline the current consultation process.
Following the CADTH summary, patient representatives Louise Binder (Save Your Skin Foundation) and Martine Elias (Myeloma Canada) offered their perspective on the proposals and helped frame the patient feedback.
After hearing from CADTH and the patients, there was time for an interactive question and answer session.
In particular, the presentation covered the following topics:
A summary of the Cancer Drug Implementation Advisory Committee (CDIAC) role and function in the cancer medication evaluation process
A review of how CADTH proposes to embed the CDIAC’s work into its pCODR process
Patient perspectives on the proposed changes
View the slide deck:
https://www.slideshare.net/jackiemant...
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - / survivornetca
Facebook - / canadiansurvivornet
Instagram: / survivornet_ca
Pinterest - / survivornetwork
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
